eli lilly ceo david ricks on q3 earnings beat, mounjaro strength
Published 11 months ago • 9K plays • Length 8:11Download video MP4
Download video MP3
Similar videos
-
5:33
eli lilly ceo david ricks on 3-year obesity drug study: this is a profound result
-
6:05
eli lilly ceo david ricks on q2 results: seeing unbelievable demand for zepbound and mounjaro
-
6:43
eli lilly ceo on weight loss drugs outlook: our top priority is making more product
-
4:26
eli lilly ceo david ricks breaks down second-quarter earnings and drug pipeline
-
4:14
eli lilly ceo david ricks on glp-1 and obesity drugs
-
2:10
i get stories every day from patients about how mounjaro is benefiting their lives: eli lilly ceo
-
3:39
eli lilly ceo david ricks on q1 earnings: this will be a year of both growth and investment
-
5:32
these are the stocks to buy for the next 10 years
-
2:40
eli lilly slashes prices of low doses of weight loss drug by scrapping auto-injector
-
2:56
eli lilly to offer weight loss drug directly to qualifying customers at lower price
-
0:55
eli lilly ceo on compounded versions of weight loss drugs
-
1:47
eli lilly results top estimates on mounjaro strength but slashes full-year profit outlook
-
4:29
eli lilly ceo david ricks breaks down q1 earnings, obesity drug trial results
-
4:39
eli lilly ceo reacts to q3 earnings miss, provides pipeline update
-
7:33
watch cnbc's full interview with eli lilly ceo david ricks
-
3:46
eli lilly ceo david ricks on positive alzheimer's drug trial data
-
4:05
vast utility for weight loss drugs will more than pay for themselves, says eli lilly ceo david ricks
-
1:54
eli lilly blows past estimates, hikes guidance as zepbound, mounjaro sales soar
-
4:22
fda approves a new alzheimer's drug from eli lilly
-
2:04
eli lilly results blow past estimates on strong zepbound launch, surging mounjaro revenue
-
3:15
mounjaro remains the single largest driver for eli lilly stock in the near term: mizuho's jared holz
-
6:49
coronavirus: eli lilly ceo david ricks on development of therapies